Navigating the FDA Communications Guidances: Best Practices

Navigating the FDA Communications Guidances: Best Practices
This Webinar will focus on now pharmaceutical, biologic, and medical device companies, including sales and marketing professionals and detail representatives, communicate about their products. In 2017, the FDA published draft guidances and rules on the First Amendment and "intended use," which is the basis for determining whether a product is regulated by the FDA. As sales and marketing witnesses are thrown to the forefront of products liability litigation, their communications with physicians often become the subject of depositions and trial testimony. The Webinar explores acceptable communications, FDA rules, risk assessment, First Amendment implications, and how to prepare for deposition and trial. Webinars are complimentary. Please note that the IADC does NOT apply for CLE Credit for its webinars. However, attendees are welcome to apply for and/or claim credit as their jurisdictions allow. Please contact your state accrediting agency for state-specific requirements and rules.
When
10/4/2017 12:00 PM - 1:00 PM
Where
UNITED STATES

Sign In